Gulf Coast Regional Blood Center Selects Digbi Health to Elevate Employee Health Programs for Weight Management, Diabetes and Digestive Issues
The Houston-area blood provider will integrate genetics and gut microbiome-based personalized care into its employee wellness program.
PALO ALTO, Calif., March 15, 2024 /Digbi Newswire/ -- Digbi Health, an innovator in personalized health technology, today announced a collaboration with Gulf Coast Regional Blood Center, a key blood provider for Houston and surrounding counties. The partnership integrates personalized health solutions based on genetics and gut biome analysis into the wellness programs of a critical healthcare provider.
Enhancing employee wellness
The Gulf Coast Regional Blood Center team will use Digbi Health's platform to optimize weight management and address physical and mental health challenges. By applying precision biology through genetics and gut microbiome analysis, the initiative aligns with the center's commitment to the health of its employees and the communities they serve. The program addresses chronic conditions including obesity, type 2 diabetes and digestive disorders, and is available to employees and their families.
A collaboration aimed at community health
Digbi Health's approach aligns with Gulf Coast Regional Blood Center's mission of community partnership to save and sustain lives, beginning with its own workforce.
This partnership is a milestone for us at Digbi Health. It embodies our commitment to transform individual chronic care by decoding our genetics, gut biome, and blood markers.
— Ranjan Sinha, CEO, Digbi Health
About Gulf Coast Regional Blood Center
Founded in 1975, Gulf Coast Regional Blood Center is an independent, nonprofit organization committed to ensuring a safe and reliable blood supply. With more than 650 employees, it serves 26 counties across Texas.
About Digbi Health
Digbi Health is the precision biology care company unifying metabolic and inflammatory care — including obesity, cardiometabolic, gastrointestinal, and inflammatory disorders. These illnesses share a root cause: a mismatch between an individual's biology and the one-size-fits-all lifestyle guidance they've been given. Digbi combines the gut microbiome, genetics, advanced blood biomarkers, and continuous digital health data to build a unique biological profile for each individual and identify what is driving their disease. AI then personalizes lifestyle treatment and, when needed, clinical treatment, delivered through the first precision-biology AI-orchestrated national telehealth platform. Through Digbi Labs, we invest in our vision of making chronic illness optional and advancing healthspan — partnering with leading universities, pharmaceutical companies, and scientific and clinical laboratories, running distributed human trials and publishing peer-reviewed research on genetics, the gut microbiome, and the use of AI to deliver care that is safe, cost-effective, and accessible. Digbi's healthcare cost reduction is documented in multiple peer-reviewed actuarial claims studies. Digbi is accessible to 30 million individuals through more than 300 employers and health plans.
SOURCE Digbi Health
- Employer Benefits
- Obesity
- Type 2 Diabetes
- Digestive Health
- Precision Biology